unikeris limited
unikeris limited Company Information
Company Number
12490954
Next Accounts
Sep 2025
Shareholders
chiesi farmaceutici s.p.a.
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
333 styal road, manchester, M22 5LG
Website
leadiantbiosciences.comunikeris limited Estimated Valuation
Pomanda estimates the enterprise value of UNIKERIS LIMITED at £99.6m based on a Turnover of £107.8m and 0.92x industry multiple (adjusted for size and gross margin).
unikeris limited Estimated Valuation
Pomanda estimates the enterprise value of UNIKERIS LIMITED at £794.4m based on an EBITDA of £85.1m and a 9.33x industry multiple (adjusted for size and gross margin).
unikeris limited Estimated Valuation
Pomanda estimates the enterprise value of UNIKERIS LIMITED at £1.1b based on Net Assets of £564m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Unikeris Limited Overview
Unikeris Limited is a live company located in manchester, M22 5LG with a Companies House number of 12490954. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in March 2020, it's largest shareholder is chiesi farmaceutici s.p.a. with a 100% stake. Unikeris Limited is a young, mega sized company, Pomanda has estimated its turnover at £107.8m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Unikeris Limited Health Check
Pomanda's financial health check has awarded Unikeris Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs
7 Strong
3 Regular
1 Weak
Size
annual sales of £107.8m, make it larger than the average company (£24.5m)
£107.8m - Unikeris Limited
£24.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 133%, show it is growing at a faster rate (5.3%)
133% - Unikeris Limited
5.3% - Industry AVG
Production
with a gross margin of 24.8%, this company has a comparable cost of product (29.5%)
24.8% - Unikeris Limited
29.5% - Industry AVG
Profitability
an operating margin of 22% make it more profitable than the average company (4.1%)
22% - Unikeris Limited
4.1% - Industry AVG
Employees
with 164 employees, this is above the industry average (36)
- Unikeris Limited
36 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Unikeris Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £657.5k, this is equally as efficient (£657.9k)
- Unikeris Limited
£657.9k - Industry AVG
Debtor Days
it gets paid by customers after 20 days, this is earlier than average (58 days)
20 days - Unikeris Limited
58 days - Industry AVG
Creditor Days
its suppliers are paid after 3 days, this is quicker than average (29 days)
3 days - Unikeris Limited
29 days - Industry AVG
Stock Days
it holds stock equivalent to 31 days, this is less than average (65 days)
31 days - Unikeris Limited
65 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is average cash available to meet short term requirements (11 weeks)
9 weeks - Unikeris Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.1%, this is a lower level of debt than the average (54.6%)
2.1% - Unikeris Limited
54.6% - Industry AVG
UNIKERIS LIMITED financials
Unikeris Limited's latest turnover from December 2023 is £107.8 million and the company has net assets of £564 million. According to their latest financial statements, we estimate that Unikeris Limited has 164 employees and maintains cash reserves of £2.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Turnover | 107,825,680 | 118,690,443 | 79,379,249 | 8,558,620 |
| Other Income Or Grants | ||||
| Cost Of Sales | 81,096,226 | 93,675,322 | 75,720,246 | 11,341,059 |
| Gross Profit | 26,729,454 | 25,015,121 | 3,659,004 | -2,782,439 |
| Admin Expenses | 2,977,452 | 2,801,462 | 6,155,457 | 1,358,313 |
| Operating Profit | 23,752,002 | 22,213,659 | -2,496,453 | -4,140,752 |
| Interest Payable | 137,559 | 460,127 | 19,993 | |
| Interest Receivable | 3,326,605 | 3,120,276 | 1,063,907 | 10,194 |
| Pre-Tax Profit | 26,941,048 | 24,873,808 | -1,452,538 | -4,130,558 |
| Tax | -5,701,832 | -458,652 | 280,775 | 780,120 |
| Profit After Tax | 21,239,216 | 24,415,156 | -1,171,763 | -3,350,438 |
| Dividends Paid | ||||
| Retained Profit | 21,239,216 | 24,415,156 | -1,171,763 | -3,350,438 |
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* | 85,109,395 | 83,556,223 | 60,640,891 | 1,005,191 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Tangible Assets | ||||
| Intangible Assets | 421,286,847 | 482,644,241 | 560,855,772 | 610,080,108 |
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 421,286,847 | 482,644,241 | 560,855,772 | 610,080,108 |
| Stock & work in progress | 6,958,552 | 4,438,376 | 7,240,078 | 13,343,060 |
| Trade Debtors | 6,072,844 | 5,838,087 | 8,790,141 | 4,655,964 |
| Group Debtors | 108,872,327 | 33,189,081 | 11,777,225 | 2,359,541 |
| Misc Debtors | 30,853,403 | 28,509,311 | 836,543 | 408,686 |
| Cash | 2,138,895 | 18,004,678 | 53,658,664 | 2,029,298 |
| misc current assets | ||||
| total current assets | 154,896,024 | 89,979,534 | 82,302,652 | 22,796,549 |
| total assets | 576,182,871 | 572,623,775 | 643,158,424 | 632,876,657 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 837,420 | 189,527 | 490,884 | 2,485,724 |
| Group/Directors Accounts | 2,915,323 | 3,263,950 | 4,445,839 | 3,112,909 |
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | 8,446,633 | 11,182,501 | 12,094,990 | 1,005,383 |
| total current liabilities | 12,199,377 | 14,635,978 | 17,031,714 | 6,604,016 |
| loans | 15,243,518 | 15,717,207 | 15,374,672 | |
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | ||||
| provisions | 75,975,269 | 86,040,175 | ||
| total long term liabilities | 15,243,519 | 91,692,478 | 101,414,848 | |
| total liabilities | 12,199,377 | 29,879,497 | 108,724,192 | 108,018,864 |
| net assets | 563,983,494 | 542,744,278 | 534,434,233 | 524,857,794 |
| total shareholders funds | 563,983,494 | 542,744,278 | 534,434,233 | 524,857,794 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | 23,752,002 | 22,213,659 | -2,496,453 | -4,140,752 |
| Depreciation | ||||
| Amortisation | 61,357,393 | 61,342,564 | 63,137,344 | 5,145,943 |
| Tax | -5,701,832 | -458,652 | 280,775 | 780,120 |
| Stock | 2,520,176 | -2,801,702 | -6,102,981 | 13,343,060 |
| Debtors | 78,262,097 | 46,132,570 | 13,979,718 | 7,424,191 |
| Creditors | 647,893 | -301,357 | -1,994,840 | 2,485,724 |
| Accruals and Deferred Income | -2,735,868 | -912,489 | 11,089,607 | 1,005,383 |
| Deferred Taxes & Provisions | -75,975,269 | -10,064,906 | 86,040,175 | |
| Cash flow from operations | -3,462,685 | -37,422,412 | 52,074,790 | 70,549,342 |
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | -348,627 | -1,181,889 | 1,332,930 | 3,112,909 |
| Other Short Term Loans | ||||
| Long term loans | -15,243,518 | -473,689 | 342,535 | 15,374,672 |
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | ||||
| share issue | ||||
| interest | 3,189,046 | 2,660,149 | 1,043,914 | 10,194 |
| cash flow from financing | -12,403,099 | -15,100,540 | 13,467,581 | 546,706,007 |
| cash and cash equivalents | ||||
| cash | -15,865,783 | -35,653,986 | 51,629,366 | 2,029,298 |
| overdraft | ||||
| change in cash | -15,865,783 | -35,653,986 | 51,629,366 | 2,029,298 |
unikeris limited Credit Report and Business Information
Unikeris Limited Competitor Analysis
Perform a competitor analysis for unikeris limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in M22 area or any other competitors across 12 key performance metrics.
unikeris limited Ownership
UNIKERIS LIMITED group structure
Unikeris Limited has no subsidiary companies.
Ultimate parent company
VALLINE SRL
#0115063
CHIESI FARMACEUTICI SPA
#0027141
2 parents
UNIKERIS LIMITED
12490954
unikeris limited directors
Unikeris Limited currently has 6 directors. The longest serving directors include Mr Andrew Dickinson (Nov 2020) and Mr Andrew Dickinson (Nov 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Andrew Dickinson | England | 54 years | Nov 2020 | - | Director |
| Mr Andrew Dickinson | 54 years | Nov 2020 | - | Director | |
| Mr Lawrence Isaacs | United Kingdom | 56 years | Jan 2022 | - | Director |
| Mr Matteo Ceni | England | 39 years | Jan 2022 | - | Director |
| Mr Tiziano Toschi | England | 54 years | Jan 2022 | - | Director |
| Mr Pier Copercini | England | 61 years | Jan 2022 | - | Director |
P&L
December 2023turnover
107.8m
-9%
operating profit
23.8m
+7%
gross margin
24.8%
+17.62%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
564m
+0.04%
total assets
576.2m
+0.01%
cash
2.1m
-0.88%
net assets
Total assets minus all liabilities
Similar Companies
unikeris limited company details
company number
12490954
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
March 2020
age
5
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
DELOITTE IRELAND LLP
address
333 styal road, manchester, M22 5LG
Bank
-
Legal Advisor
-
unikeris limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to unikeris limited.
unikeris limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for UNIKERIS LIMITED. This can take several minutes, an email will notify you when this has completed.
unikeris limited Companies House Filings - See Documents
| date | description | view/download |
|---|
